Skip to main content
. 2018 Dec 27;13(12):e0208583. doi: 10.1371/journal.pone.0208583

Table 1. Baseline characteristics of study participants with discordant RDT results.

Variables 2014
(n = 361)
2015 (n = 582) 2016
(n = 424)
Total (N = 1367)
n(%) n(%) n(%) n(%)
Sex*  
Male 266(73.7) 431(74.1) 298(70.3) 995(72.8)
Female 95(26.3) 151(25.90 126(29.7) 372(27.2)
Patients' age groups(years)*  
<5 29(8.0) 50(8.6) 34(8.0) 113(8.3)
5–17 26(7.2) 40(6.9) 25(6.0) 91(6.7)
18–25 253(70.1) 405(69.6) 314(74.1) 972(71.1)
>25+ 53(14.7) 87(14.9) 51(12.0) 191(14.0)
Health facilities*  
Bulombora 104(28.8) 17(2.9) 9(1.1) 130(9.5)
Chita 0(0.0) 80(13.7) 64(15.1) 144(10.5)
Maramba 78(21.6) 228(39.2) 96(22.6) 402(29.4)
Mgambo 60(16.76) 116(19.9) 144(33.9) 320(23.4)
Msange 0(0.0) 35(6.0) 52(12.3) 87(6.4)
Ruvu 71(19.7) 106(18.2) 34(8.0) 211(15.4)
Rwamkoma 48(13.3) 0(0.0) 25(6.0) 73(5.3)
Type of discordant results*  
False negative results 245(67.9) 346(59.5) 231(54.5) 822(60.1)
False positive results 116(32.1) 236(40.5) 193(45.5) 545(39.9)
Patients eligible for follow-up**  
Eligible 200(55.4) 282(48.4) 217(51.2) 699(51.1)
Not eligible 161(44.6) 300(51.6) 207(48.8) 668(48.9)

* p≤0.001

** p≥0.001